Ingredient

Dacomitinib Hydrate

Dacomitinib hydrate is an anticancer active ingredient that inhibits the growth of specific cancer cells.

See medicines used for Others & Special
All medicines
3
Single ingredient
3
Prescription medication
3

MFDS ingredient code M270711

What does it do?

Dacomitinib hydrate belongs to the class of tyrosine kinase inhibitors and is primarily used in the treatment of non-small cell lung cancer, included in pharmaceuticals to prevent the proliferation of cancer cells.

This ingredient blocks the activity of a specific receptor on the surface of cancer cells, EGFR, disrupting the signaling required for cancer cell growth and division. As a result, the proliferation of cancer cells is inhibited, and the progression of tumors is slowed.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Dacomitinib hydrate is an irreversible EGFR inhibitor that, unlike other EGFR inhibitors, binds strongly to the receptor to produce a sustained inhibitory effect. This differentiates it by showing efficacy against resistant cancer cells.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Category
Dosage form
Strength
Category

3 total

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

SourceKorea Ministry of Food and Drug Safety (Drug Safety Korea)

Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.